The global infertility treatment market was valued at USD 1.9 billion in 2023 and it is anticipated to grow further up to USD 4.1 billion by 2033, at a CAGR of 8.2% during the forecast period.
The inability of a person to reproduce naturally is known as infertility. There are several causes of infertility. The few causes include the aging of the mother, ovulatory problems, tubal obstruction or blockage, sex-transmitted diseases, immunological infertility, genetics, and infertility brought on by male factors. One way to treat infertility is to raise awareness. Other alternatives include IVF (in vitro fertilization), insemination, and drugs that help the body develop during the ovulation phase. The fertility procedure in which the body processes the sperm and eggs out of the body is referred to as assisted reproductive technology (ART). In an ART operation, a woman’s ovaries are surgically removed, her eggs are fused with sperm in a lab, and either she returns the eggs to her body or donates them to another woman. With the aid of many diagnostic techniques, including ultrasound, physical examination, and evaluating sperm count & quality, among others, infertility can be identified in both men and women.
View The Full Report Here –https://www.globalinsightservices.com/reports/infertility-treatment-market/
Market Trends and Drivers
Due to a variety of circumstances, including the rising trend of late marriages and the rise in age-related infertility, the fertility rate globally is progressively dropping. By 2030, it is predicted that there will be 2.4 offspring for every woman worldwide, and by 2050, there will be 2.2. The need for infertility treatment items that identify the reproductive window in males and females has significantly increased as a result of the dropping fertility rate.
Similarly, players in the infertility treatment market can expect to find considerable growth possibilities in emerging markets like China, India, Brazil, and Mexico. The increased emphasis on healthcare infrastructure upgrades is what distinguishes the market for infertility treatments in Asia and other emerging nations. The medical tourism sector is also flourishing in developing nations for a variety of reasons. Numerous doctors and surgeons throughout Asia have received their training at prestigious institutions in the US and Europe, and healthcare facilities and procedures are of a high standard. Emerging nations like India, China, Singapore, Thailand, Brazil, and Malaysia offer a lot of potential for the expansion of the market for infertility treatments. Players are increasingly focusing on strategic agreements/partnerships with regional/domestic players, geographical expansions, and acquisitions to increase their presence in these markets and tap a large number of customers in order to take advantage of the significant growth opportunities in emerging countries. Additionally, government measures to make infertility treatments more accessible as well as the rise in fertility clinics are causing an increase in infertility treatment procedures in developing nations.
Market Restraints and Challenges
Thousands of rounds of ART procedures including in vitro fertilization (IVF) are carried out year across the globe in addition to reproductive surgery. Due to the absence of reimbursement policies, the cost of IVF therapy varies from nation to nation. The development of this market is being constrained by a lack of insurance coverage and a problematic reimbursement environment in several regions of the world.
COVID-19 Impact
Currently, the coronavirus pandemic is posing a number of difficulties for patients and clinical healthcare professionals all around the world. The main hurdles facing healthcare systems around the world are logistical problems, managing patients with the disease, prioritizing patients with comorbidities and pre-existing disorders, and protecting public and hospital frontline employees from contact with the COVID-19 virus. Infertility affects one in six couples of reproductive age, and many of them seek out therapies like intrauterine insemination (IUI) and in vitro fertilization (IVF), which call for in-person consultations to be completed. Only 5 lakhs of the 30 lakh persons who seek infertility treatment in India each year actually have IVF or intrauterine insemination (IUI) procedures done. During the COVID-19 epidemic, there was a 90% decrease in the number of IVF cycles performed. The spread of COVID-19 has had an impact on couples that were considering IVF treatment prior to the pandemic as well as fertility clinics due to the cancellation of IVF procedures.
Unlock Growth Potential in Your Industry – Get Your Sample Report Now–https://www.globalinsightservices.com/request-sample/GIS10305
Global Infertility Treatment Market Segmentation
By Product
- Equipment
- Media & Consumables
- Accessories
By Procedure
- Assisted Reproductive Technology
- Artificial Insemination
- Fertility Surgeries
- Others
By Patient Type
- Female
- Male
By End User
- Fertility Centers
- Hospitals & Surgical Clinic
- Cryobanks
- Research Institutes
Major Players in the Global Infertility Treatment Market
The key players studied in the report are The Cooper Companies Inc. (US), Cook Group (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), ZEISS Group (Germany), and MedGyn Products, Inc. (US) among others.
Buy Now-https://www.globalinsightservices.com/checkout/single_user/GIS10305
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Infographic excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.